| B-cell malignancies | |
| ALL | 2/2 |
| CLL | 12/15 |
| MCL | 5/5 |
| HCL | 1/2 |
| MM | 4/4 |
| T-cell malignancies | |
| ALL | 1/1 |
| Sézary | 1/1 |
| Acute myeloid leukemia | |
| AML | 8/16 |
| B-cell malignancies | |
| ALL | 2/2 |
| CLL | 12/15 |
| MCL | 5/5 |
| HCL | 1/2 |
| MM | 4/4 |
| T-cell malignancies | |
| ALL | 1/1 |
| Sézary | 1/1 |
| Acute myeloid leukemia | |
| AML | 8/16 |
ALL indicates acute lymphocytic leukemia; CLL, chronic lymphocytic leukemia; MCL, mast cell leukemia; HCL, hairy cell leukemia; MM, multiple myeloma; AML, acute myeloid leukemia.
Cells were stained with biotinylated HLy-9.1.84 mAb. This was followed by incubation with avidin-phycoerythrin and analysis by flow cytometry. An unreactive mAb was used as negative control. Results represent positive samples versus analyzed samples.